StockSelector.com
  Research, Select, & Monitor Saturday, August 17, 2019 7:30:34 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Clovis Oncology Inc$5.60$.407.69%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Clovis Oncology Inc has an overall rank of 6352 out of 7126 stocks based on 6 positive rankings and 14 negative rankings.

Positive Rankings
Oversold RSI
The 14 Day Relative-Strength Index for Clovis Oncology Inc is 19.0. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, Clovis Oncology Inc is ranked 53.
Estimated Revenue Growth
Clovis Oncology Inc rank is 111
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Clovis Oncology Inc is ranked 172.
Low vPut/Call
Clovis Oncology Inc has a low Put/Call ratio of 0.12 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Clovis Oncology Inc is ranked 238.
PEGValue
Clovis Oncology Inc has a PEG Value of $12.25. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 118.84% in the next year. Among companies with a PEG Value above the current stock price, Clovis Oncology Inc is ranked 301.
Oversold Stochastics
Clovis Oncology Inc rank is 467
Negative Rankings
10 Day Loss
Clovis Oncology Inc rank is 62
90 Day Loss
Clovis Oncology Inc rank is 74
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Clovis Oncology Inc is ranked 87.
Negative ROE
Clovis Oncology Inc rank is 158
Negative Guidance
Within the past 90 days Clovis Oncology Inc has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
Negative Net Margin
Clovis Oncology Inc rank is 314
Missed Whisper
According to EarningsWhispers.com, Clovis Oncology Inc missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
Negative ROA
Clovis Oncology Inc rank is 607
Debt-to-Equity
Clovis Oncology Inc rank is 823
Negative Cash Growth
Clovis Oncology Inc rank is 914
Down EPS Surprise
Clovis Oncology Inc missed the consensus earnings estimate when it last reported quarterly earnings.
High Put/Call
Clovis Oncology Inc has a high Put/Call ratio of 0.80 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Clovis Oncology Inc is ranked 1214.
Price-to-Sales
Clovis Oncology Inc rank is 1987
Price-to-Book
Clovis Oncology Inc rank is 2089







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.